Semaglutide in Research: GLP-1 Receptor Agonist Mechanisms
A review of semaglutide research examining its mechanism of action as a GLP-1 receptor agonist, pharmacokinetic properties, and current areas of scientific investigation.

Are you over 21 years of age and do you confirm this is for research use only?
RUO — Research Use Only: Our products are strictly intended for research, laboratory, or analytical purposes and are not for human consumption. By accessing this site and purchasing these items, you agree to utilize them in accordance with the law. It is your responsibility to understand the legal parameters governing their use.
An overview of TB-500 (Thymosin Beta-4 fragment) research, covering its role in actin regulation, cell migration studies, and current areas of preclinical investigation.
Research Use Only Disclaimer: This article is provided for informational and educational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, cure, or prevent any disease. All compounds discussed are for laboratory research use only and are not intended for human consumption.
TB-500 is a synthetic peptide fragment corresponding to the active region of Thymosin Beta-4 (Tβ4), a 43-amino acid naturally occurring peptide found in virtually all mammalian cell types. Tβ4 is one of the most abundant intracellular peptides and plays a fundamental role in actin cytoskeleton dynamics. This article reviews the current state of TB-500 research.
Research Use Only: TB-500 is sold exclusively for laboratory research purposes and is not approved for human therapeutic use.
The primary known function of Tβ4 is the sequestration of monomeric G-actin, preventing its polymerization into F-actin filaments. This regulation of the actin cytoskeleton is critical for:
TB-500 contains the central actin-binding domain of Tβ4, specifically the sequence LKKTETQ (amino acids 17-23). This tetrapeptide motif is responsible for the G-actin sequestering activity and has been the focus of extensive structural biology research.
In vitro wound healing assays (scratch assays) have been widely used to study TB-500's effects on cell migration. Published findings include:
TB-500 has been studied in angiogenesis models, including:
Laboratory studies have investigated TB-500's potential anti-inflammatory properties:
| Property | TB-500 (Fragment) | Thymosin Beta-4 (Full) |
|---|---|---|
| Amino Acids | ~17 (active region) | 43 |
| Molecular Weight | ~1.6 kDa | ~4.9 kDa |
| Actin Binding | Yes (LKKTETQ motif) | Yes (full binding domain) |
| Stability | Higher (smaller fragment) | Lower (more degradation sites) |
| Research Use | Widely available | Less commonly available |
For optimal research results:
Most TB-500 research has been conducted in cell culture and animal models. Key limitations include:
TB-500 remains a valuable research tool for studying actin dynamics, cell migration, and related biological processes. As analytical methods improve and research protocols become more standardized, our understanding of this peptide's mechanisms will continue to advance.
This article is provided for informational and educational purposes only. All compounds discussed are for laboratory research use only and are not intended for human consumption.
The information in this article is intended for research and educational purposes only. These products are not dietary supplements and have not been evaluated by the FDA. They are not intended to diagnose, treat, cure, or prevent any disease. Only qualified researchers should handle these compounds in controlled laboratory settings.
A review of semaglutide research examining its mechanism of action as a GLP-1 receptor agonist, pharmacokinetic properties, and current areas of scientific investigation.
A review of tirzepatide research examining its unique dual GIP/GLP-1 receptor agonist mechanism, structural innovations, and emerging areas of scientific investigation.
An in-depth review of published research on BPC-157 (Body Protection Compound-157), examining its molecular mechanisms, in vitro findings, and future research directions.